iHerb Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
AsiaNet 90801
PASADENA, Calif., July 22, 2021 /PRNewswire=KYODO JBN/ --
iHerb Holdings, Inc. today announced that it has confidentially submitted a
draft registration statement on Form S-1 with the Securities and Exchange
Commission (the "SEC") relating to the proposed initial public offering of its
common stock. The number of shares to be offered and the price range for the
proposed offering have not yet been determined. The initial public offering is
expected to commence after the SEC completes its review process, subject to
market and other conditions.
Logo - https://mma.prnewswire.com/media/742063/iHerb_Logo.jpg
This press release does not constitute an offer to sell or the solicitation of
an offer to buy any securities. Any offers, solicitations or offers to buy, or
any sales of securities will be made in accordance with the registration
requirements of the Securities Act of 1933, as amended ("Securities Act"). This
announcement is being issued in accordance with Rule 135 under the Securities
Act.
About iHerb
We are the world's largest eCommerce platform dedicated to the Vitamins,
Minerals, Supplements, or VMS, category, with a growing presence in other areas
of consumer health and wellness. Trusted by millions in over 185 countries, we
offer a curated portfolio of branded and innovative third-party and proprietary
products at the best possible value, conveniently delivered directly to our
customers.
Source - iHerb
CONTACT: Nicole Rohrer, Director, Brand and Content, press@iherb.com;
Cassandra Bujarski/Steven Goldberg, Sard Verbinnen & Co., iherb-SVC@sardverb.com
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。